The Netherlands
Dopharma B.V. is an independent Dutch veterinary pharmaceutical family-owned company, established in 1969. The organization has over 300 employees encompassing various roles such as production staff, analytical chemists, scientists, veterinarians, laboratory workers, shipping employees, administrators, and marketing and sales people. Dopharma primarily operates in the health care, manufacturing, and pharmaceutical industries.
In the Netherlands, Dopharma holds a strong market position, delivering directly to veterinarians and through veterinary wholesalers. Dopharma Veterinaire Farmaca is a market leader in the field of antimicrobial products for consumption animals. The company's product range covers anthelmintics, analgesics, anaesthetics, and vitamin and mineral specialties. Additionally, Dopharma International manages all activities outside the domestic market through an extensive network of exclusive agents and distributors covering approximately 70 countries. The company also has its own Marketing & Sales organizations located in the Netherlands, Belgium, Romania, Germany, and Lithuania (Baltic).
Currently, Dopharma does not have any publicly disclosed recent investment.
This analysis provides insight into Dopharma's extensive experience and long-standing presence in the veterinary pharmaceutical industry. With its robust infrastructure and market leadership, Dopharma presents a compelling opportunity for potential investors to consider, particularly within the health care and pharmaceutical sectors.
